Weekly Roundup -
June 10, 2026
Smart. Strategic. Essential.
Unmatched Healthcare Insights from HMA,
Leavitt Partners & Wakely.
Featured:
A Summer Webinar Series: Understanding Work and Community Engagement Requirements and New Section 1115 Guidance
ACCESS WEBINARFinal 2027 Notice of Benefit and Payment Parameters Notice: What States and Issuers Need to Know
READ BRIEFTrending: In Focus
Act Now to Implement Community Engagement Requirements
On June 2, 2026, the Centers for Medicare & Medicaid Services (CMS) issued the highly anticipated Interim Final Rule (IFR) on implementing the Medicaid work and community engagement requirements set forth in the 2025 budget reconciliation act, P.L. 119-21. States are expected to implement the requirements by January 1, 2027, leaving Medicaid authorities, health plans, providers, and community-based partners with a compressed timeline to design, test, and deploy new workflows that will fundamentally change how eligibility and compliance are administered.
This article builds on Health Management Associates (HMA) colleagues’ ongoing analysis of federal Medicaid policy changes stemming from the Working Families Tax Cut Act and evolving federal priorities (see Connecting the Dots here and here) and explores the implications for enrollees, state agencies, health plans, and providers.
Community engagement requirements create risk and exposure for all of these interest-holders, opening them to the possibility of increased enrollment churn, particularly during the early stages of implementation as enrollees and administrators adapt to new processes. Even Medicaid enrollees who meet compliance requirements or qualify for exemptions could experience temporary coverage losses or disruptions because of delays in documentation, notice response, or case processing.
Plans and providers, meanwhile, may encounter downstream effects on capitation rate adequacy, financial and membership forecasting, risk adjustment, care management continuity, quality performance, and network stability.
From Policy to Practice: A Systemwide Operational Shift
Many elements of the IFR align with statutory provisions; however, it introduces new operational expectations that will reshape eligibility processes, including:
- Structured verification and documentation requirements
- Expanded exemption frameworks tied to functional ability to work
- New reporting and oversight obligations
- Increased reliance on enrollee notifications and engagement
Collectively, these changes introduce a new layer of administrative expectations that extend beyond traditional eligibility and enrollment functions and require coordination across state and local agencies, health plans and providers, and community partners.
Notably, CMS has provided targeted flexibilities—particularly through income-based compliance pathways—which will allow states to leverage existing data sources and potentially reduce administrative burden, if implemented effectively.
States Need to Build an Operational Foundation
For state Medicaid agencies, the immediate priority is translating federal requirements into scalable, consistent processes.
Key actions include:
- Redesign eligibility and compliance workflows. States will need to identify affected populations, track compliance, adjudicate exemptions and hardships, and manage appeals—all within tight implementation timelines.
- Invest in verification infrastructure. Although automation opportunities exist, particularly using income and existing eligibility data, many determinations (e.g., medical frailty, caregiving, hardship) will require individualized review and new documentation standards.
- Strengthen cross-agency coordination and data integration. Effective implementation will depend on integrating data from workforce, social services, and other programs to support compliance and reduce manual processes.
- Develop robust communication strategies. Experience from prior Medicaid initiatives demonstrates that coverage loss often results from administrative barriers, not ineligibility, making clear, proactive communication essential.
- Balance automation and administrative complexity. States that effectively leverage automation and streamline enrollee-facing processes will be better positioned to maintain coverage continuity while meeting federal requirements.
Implications for Health Plans: Expanding the Role of Member Engagement
Health plans will play a pivotal role in implementation, although they cannot determine enrollee compliance with the new requirements. States rely on plans to identify members who may be subject to community engagement requirements, to assist with member communications, and to connect members with resources that support compliance or exemption eligibility. Even though these activities occur outside the traditional managed care financing framework, plans may be called upon to accomplish the following:
- Enhance outreach and education capabilities. Plans are often the primary point of contact for members and will need to support awareness, compliance, and navigation of new requirements.
- Identify and support at-risk populations. Plans can help flag members likely to qualify for exemptions and assist with documentation and care coordination to reduce inappropriate disenrollment.
- Prepare for enrollment volatility. Increased churn driven by documentation delays and administrative barriers may affect financial performance, care continuity, and quality outcomes.
- Align with state expectations and funding constraints. Because these activities fall outside traditional Medicaid benefits, states and plans must carefully define roles, accountability, and funding mechanisms.
Implications for Providers: A New Interface with Eligibility Systems
Providers, particularly safety net organizations, will be directly affected by new documentation and enrollee support responsibilities and should be prepared to address the following:
- Expand administrative and clinical workflows. Providers will increasingly be asked to support medical frailty determinations, document functional limitations, and provide verification related to exemptions.
- Prepare for increased administrative burden. New documentation requirements and coordination with plans and states will require operational adjustments, particularly for organizations serving large Medicaid populations.
- Mitigate impacts of coverage disruption. Gaps in coverage—often tied to procedural barriers—may disrupt care continuity, particularly for high need populations, and increase uncompensated care.
- Serve as a critical partner in engagement efforts. Providers are uniquely positioned to identify at-risk individuals, educate patients, and support compliance, making them essential to implementation success.
Many of the most complex determinations—such as medical frailty and caregiving—cannot be fully automated, requiring nuanced policy design and consistent operational execution. As a result, successful implementation will depend on the following:
- Standardized documentation and review processes
- Integrated data systems and verification pathways
- Clear division of responsibilities across interest-holders
- Coordination across policy, operations, and frontline personnel
Act Now to Influence Community Engagement Rollout
States and stakeholders face dual, immediate priorities—preparing for implementation and engaging in the federal rulemaking process. CMS is accepting comments on the IFR through July 31, 2026, creating a critical opportunity to shape final policy while building operational readiness. At the same time, the compressed timeline to 2027 for implementation underscores the need for rapid decision-making on policy design, systems investments, and partner engagement.
The Medicaid community engagement requirements represent one of the most significant operational transformations in the program’s 60-year history. To succeed, organizations should act early, coordinate with interest-holders, and design implementation strategies that balance compliance, administrative efficiency, and coverage continuity.
Now is the time to:
- Establish cross-functional governance and implementation plans
- Evaluate verification strategies and data integration opportunities
- Define roles and expectations across plans, providers, and partners
- Develop targeted communication and engagement strategies
- Conduct readiness assessments and system testing
HMA can actively support state policymakers, health plans, and providers as they in navigate these challenges. For details, access the full HMA Issue Brief and explore the Community Engagement State Support Hub.
New Funding Approaches Prompt Maryland Healthcare Leaders to Reassess Strategies for Affordable Coverage
Strategies to improve healthcare delivery, sustain coverage, and manage growing cost pressures resulting from federal policy changes and state budget dynamics were key topics of discussion at this year’s Maryland health policy conference, May 21, 2026, in Baltimore, MD. Hosted by State of Reform (SOR), an HMA Company, the program convened state policymakers and leaders of health plans, provider groups, and community-based organizations to examine the most pressing healthcare issues in Maryland.
Across sessions, participants explored key policy priorities, including Maryland’s implementation of the Rural Health Transformation Program (RHTP), efforts to stabilize and expand health insurance coverage, and early lessons from implementing the AHEAD (Achieving Healthcare Efficiency through Accountable Design) total cost of care (TCOC) model.
Sustaining Medicaid and Marketplace Accessibility Amid Federal Policy Changes
Throughout the conference speakers and attendees engaged on myriad issues and concerns resulting from the 2025 budget reconciliation act, now referred to as the Working Families Tax Cuts (WFTC) Act, and its potential impact on state Medicaid programs and coverage stability. Maryland Deputy Secretary for Healthcare Financing and Medicaid Director Perrie Briskin joined Johanna Fabian-Marks, Deputy Executive Director of the Maryland Health Benefit Exchange (MHBE), and Melissa Horn, Director of State Legislative Affairs at the Arthritis Foundation, to examine strategies for mitigating coverage loss and maintaining affordability.
Speakers emphasized the need for improved coordination between Medicaid and the MHBE, including clear and consistent consumer communications and targeted outreach in counties most affected by federal policy changes.
For example, Maryland leaders described several innovative approaches the MHBE is using to help people in the state maintain Marketplace coverage, including state-funded subsidies to offset the expiration of enhanced premium tax credits, streamlined auto-renewals, and simplified enrollment pathways for individuals identified as uninsured based on their tax and employment records. The state reported an 8 percent decline in enrollment in April 2026, noting that without these mitigation strategies, enrollment could have dropped by as much as one-third.
The MHBE is using artificial intelligence (AI) to support document verification and is deploying a chatbot to help consumers navigate common questions.
On the Medicaid side, the state is consulting multiple data sources—including CRISP (Chesapeake Regional Information System for our Patients), labor, and education data—to verify eligibility and, compliance with community engagement requirements to reduce administrative burdens.
Rural Health Transformation Program Implementation and Early Priorities
Maryland’s RHTP, supported by nearly $168.2 million in first-year funding from the Centers for Medicare & Medicaid Services (CMS), was a hot topic at the conference. State leaders and implementation partners emphasized the program’s role in addressing rural health disparities, strengthening care delivery infrastructure, and improving chronic disease outcomes.
Elizabeth Kromm, PhD, Assistant Secretary, Maryland Department of Health, outlined the three pillars of the state’s RHTP plan:
- Expand the rural healthcare workforce
- Increase access to integrated primary, specialty, and behavioral health services
- Address the underlying drivers of chronic disease through nutrition and food system interventions
Together, these initiatives highlight Maryland’s focus on both clinical care delivery and broader population health strategies.
State officials also discussed the funding opportunities announced in April 2026, one of which seeks to support care delivery innovation, improve chronic condition management, and advance value-based care models. Speakers emphasized that connection is central to the program’s success—both the strength of community relationships, the connections enabled through technology, and the integration of clinical and nonclinical services.
AHEAD Model: Advancing Total Cost of Care and Population Health
Maryland’s participation in CMS’s AHEAD Model represents a significant shift toward healthcare cost containment and system transformation. As one of the first states to implement the framework, Maryland is testing a statewide approach to managing TCOC while improving quality and population health outcomes.
A panel discussion including leaders from the MedChi, Johns Hopkins, CareFirst Blue Shield, and Kaiser Permanente, addressed implementation considerations, open policy implications, and how providers and payers were approaching these changes in payment for healthcare services. Reimbursement strategies for primary care services were still uncertain and may differ significantly from those used under the Maryland TCOC model. Panelists also discussed what this model means in the broader healthcare environment of reductions in Medicaid payments resulting from the reconciliation legislation and additional funding coming from the Rural Health Transformation Fund. They also described how Maryland could serve as an example for other states working to implement AHEAD in the coming years.
Speakers noted that successful implementation will require strong coordination among providers, payers, and state agencies, and more details are necessary to fulfill the requirements. The model’s 10-year timeline positions Maryland as a leading test case for future federal and state efforts to scale TCOC approaches.
AI in Healthcare: From Innovation to Real-World Impact
AI’s role in healthcare delivery and policy continues to evolve, with growing attention on its practical applications and regulatory implications. A session led by Health Management Associates (HMA) Principal Brandon Greife, JD, and speakers from Microsoft AI, the Pair Team, the Center for Virtual Care, and b.well Connected Health explored how healthcare organizations conceptualize AI use cases to deploy solutions that demonstrate measurable impact.
AI holds promise for improving care delivery, but realizing that potential requires navigating ethical, regulatory, and operational challenges. Mr. Greife led a panel discussion on how the healthcare industry is transitioning from abstract use cases for AI toward evaluating the real-world impact of deployed solutions.
Session speakers also explored how healthcare is advancing from AI tools that support clinicians and payers to patient-facing AI that supports care navigation, chronic disease management, and community outreach. They rounded out the session with a focus on fundamentals of healthcare—concepts like data quality, clinical trust, patient safety, and demonstrated value at the point of care.
Looking Ahead
If you are looking for strategies and solutions to address urgent healthcare policy and operational challenges, HMA experts are available to help you navigate these complex changes and identify practical paths forward.
Through the HMA National Conference, State of Reform partnership events, and other HMA convenings across the country, we connect state leaders, providers, health plans, and community stakeholders to share insights, elevate lessons, and advance solutions. Join us at an upcoming event—including our next HMA National Conference in New Orleans, LA on October 5-7, 2026—or explore additional opportunities to engage with HMA and access the full schedule of conferences and resources.
State of Reform develops its conference agendas through collaboration with HMA subject matter experts/market leads and stakeholders across the public and private sectors, including state officials, community-based organizations, providers, payers, and more.
Federal Policy News
Fueled By Leavitt Partners Weekly Health Intelligence
FY 2027 Funding Debate Takes Shape for HHS, NIH, CDC, and FDA
In recent weeks, the US House of Representatives has been focusing on advancing appropriations bills to fund the government for fiscal year (FY) 2027, including US Department of Health and Human Services (HHS) and its operating agencies.
Last week, the House Appropriations Labor, Health and Human Services, Education, and Related Agencies (LHHS) Subcommittee held a markup of the FY 2027 LHHS Appropriations bill. The subcommittee advanced the legislation to the full Appropriations Committee with a vote of 11 to 7, without amendment. The bill provides an overall 4 percent reduction in discretionary funding for HHS, versus the 12.5 percent reduction proposed in the President’s FY 2027 budget. The Committee Report language again acknowledges that the Administration proposed to reorganize HHS, including consolidating several agencies into a new Administration for a Healthy America. As in last year’s conferenced report, the House Appropriations Committee states that, “The Committee applauds these efforts to improve efficiency while reducing waste, fraud, and abuse. The Committee notes that the authorizing committees of jurisdiction have not yet had the opportunity to consider every reorganizational proposal.” As such, the appropriations bill and committee report “do not make significant changes to the organizational structure of the agencies funded herein.”
Specific HHS funding provisions include:
- $48.8 billion in discretionary funding for NIH, a $100 million increase from FY 2026 and $5.8 billion increase from the President’s budget request;
- $6.7 billion in discretionary funding for CDC, a $1.0 billion decrease from FY 2026 and $582 million increase from the President’s budget request;
- $8.1 billion in discretionary funding for HRSA, a decrease of $877.8 million from FY 2026 and $1.9 billion increase from the President’s budget request;
- $3.6 billion in program level funding for ASPR, a $44.0 million decrease from FY 2026 and $311.5 million increase from the President’s budget request; and
- $7.3 billion in program level funding for SAMHSA, a $145.3 million decrease from FY 2026 and $609.1 million increase from the President’s budget request.
Additionally, on June 4, the House passed H.R. 8646, the Agriculture, Rural Development, Food and Drug Administration, and Related Agencies Appropriations Act, 2027, by a vote of 213 to 210. The bill reduces overall discretionary spending for the agencies by 1.4 percent. For FDA, the bill increased the overall budget to $7.1 billion, a 4.4 percent increase from FY 2026. This includes $3.36 billion (a 5 percent increase) in discretionary budget authority and $3.74 billion (a 3.8 percent increase) in definite user fees. The Senate Appropriations Committee has yet to mark up its version of the legislation, which was slated for June 4 but delayed. The two versions of the legislation will ultimately have to be reconciled before being sent to the President’s desk for signature.
FDA’s New Priority Voucher Program Draws Praise and Questions
On June 4, FDA held a public hearing on the Commissioner’s National Priority Voucher (CNPV) program. The CNPV program was originally established under the leadership of then-FDA Commissioner Marty Makary, who has since left the role, with the goal of expediting drug product reviews for companies focused on national priorities including public health crisis, innovative cures, large unmet needs, onshoring, and affordability. During his tenure, the CNPV program was met with criticism from Congressional Democrats, including the ranking members of the Senate HELP Committee and House Energy and Commerce Committee. The June 4 public hearing included a listening panel comprised of leaders from the Office of the Commissioner, the Center for Drug Evaluation and Research (CDER), the Center for Biologics Evaluation and Research (CBER), and the Oncology Center of Excellence who heard remarks and responded to questions from stakeholders including pharmaceutical manufacturers and physician and patient advocacy organizations. Many of these stakeholders praised the program’s potential to accelerate patient access to critical therapies, but also expressed concerns regarding the transparency around the program’s procedures, as the criteria to be selected for a voucher is not publicly available, leaving many sponsors of therapies without a predictable outcome of their voucher application. One commentator also expressed concern that, without formal and transparent regulatory processes in place, approvals made through the program could be subject to legal challenges. Other commentors expressed the desire to include more career officials as well as patients and physicians involved in the approval process for therapies selected by the CNPV program, including specialists with subject matter expertise specific to the patient population.
In addition to the hearing, FDA has established a docket for comments on the CNPV program including public views on the scope of the program, potential changes to the scope, the selection process, timeline for product reviews, and metrics to evaluate the program. Comments must be submitted by June 29, 2026, at 11:59pm ET.
What the Return of Schedule F Means for Federal Health Agencies
On June 3, President Trump published an Executive Order (EO) to reclassify nearly 8,000 federal employee titles as Schedule F,” or “Schedule Policy/Career.” Under the rescheduling, individuals in “confidential, policy-determining, policy-making, and policy-advocating roles (policy-influencing positions)” will now considered a separate schedule of federal employees that can be “removed for misconduct or poor performance.”
The EO includes an appendix detailing which positions across the U.S. government will be impacted and directs the head of each agency to notify employees of their new placement as Schedule Policy/Career and to conform agency records accordingly within one week of the order.
It is estimated that approximately 400 positions within HHS will be subject to Schedule F reclassification.
- At NIH, deputy directors and branch chiefs will be affected by Schedule F, which impacts oversight of grant portfolios and project management.
- At CDC, a wider range of officials will have their positions reclassified, including researchers, biologists, epidemiologists, public health officials, and communication specialists.
- At FDA, the shift will impact a number of cross-cutting staff, including deputy division directors who oversee review staff, senior health policy analysts and advisors, senior science policy analysts and advisors, public health advisors, communications officers, and senior congressional affairs specialists.
- At CMS, health insurance specialists, who oversee federal health insurance programs, and budget analysts will be reclassified as Schedule Policy/Career.
Ready to talk about your organization's challenges?
Schedule a ConsultationState Policy News
Idaho Announces First Round of RHTP Funding Opportunities
The Idaho Department of Health and Welfare (DHW) announced on June 9, 2026, that the first round of funding opportunities for the Rural Health Transformation Program (RHTP) is open for Project Management Support, the Perinatal Quality Collaborative, and OB Readiness. The OB readiness funding opportunity makes up to $1.2 million available for one organization that would serve as the lead entity supporting rural providers to enhance obstetric readiness at both birthing and non-birthing facilities, as well as help launch a quality improvement initiative with an Obstetric Emergency Readiness Resource Kit. The Perinatal Quality Collaborative funding opportunity will give up to $2.4 million to one organization that will serve as the lead entity to help increase the number of rural hospitals completing one or more perinatal collaborative initiatives by December 31, 2030. Applications for both opportunities are due July 10, 2026.
Illinois Finalizes $431B Medicaid Managed Care Awards, Setting Stage for Operational and Market Changes
The Illinois Department of Healthcare and Family Services issued on June 8, 2026, a notice of award for the HealthChoice Illinois Medicaid managed care procurement to incumbents CVS/Aetna Better Health, HCSC/Blue Cross Blue Shield of Illinois, Centene/Meridian Health Plan, and Molina, along with non-incumbent Humana, for statewide contracts and incumbent Cook County Health/CountyCare Health Plan for the Cook County-only contract.
The contracts include a 4.5-year initial term and a 5.5-year renewal term, with a total estimated award amount of $431.4 billion for 10 years. Plans will cover families and children, Medicaid expansion adults, special needs children, individuals with disabilities, and other Medicaid-eligible individuals who are not eligible for Medicare. Each plan will also be required to execute two contracts: the HCI Model Contract for Federally Funded Managed Care Services and the HCI Model Contract for State Funded Managed Care Services, to comply with the Centers for Medicare & Medicaid Services 2025-2026 Medicaid Managed Care Rate Development Guide, which requires state-funded services to be placed in a distinct contract vehicle. This procurement focused on the delivery of benefits and services for Medicaid enrollees with complex medical and behavioral health needs; maternal and reproductive health; preventative care; home and community-based services; pharmacy services; social determinants of health; NEMT; and care coordination among others.
Montana Advances Work on Medicaid Community Engagement Requirements to Meet July 1 Deadline
The Montana Department of Public Health and Human Services (DPHHS) is moving forward with its July 1 deadline to implement Medicaid community engagement requirements, despite new questions that have risen after the Centers for Medicare & Medicaid Services (CMS) released an interim final rule on the new provision. Advocates expressed concern over the way people are determined to be medically frail. The new guidance states that individuals must prove they are unable to work in addition to having a diagnosis, but it does not specify how an individual could prove their inability to work. DPHHS officials stated that the new guidelines do not change the implementation timeline and they are working on defining what conditions are considered medically frail.
North Dakota Governor Announces Medicaid Oversight Changes
North Dakota Governor Kelly Armstrong announced multiple changes to Medicaid fraud oversight in response to the federal government’s call to revalidate high risk Medicaid providers. The state’s Health and Human Services (HHS) will expand oversight of qualified service providers, non-emergency medical transportation (NEMT) providers, and 1915(i) home and community-based service providers starting July 1, 2026. The increased oversight will include more frequent provider revalidation, stricter enrollment rules, additional competency checks, and increased site visits. In addition, North Dakota is pausing enrollments of NEMT providers statewide as well as other providers in Cass and Burleigh counties.
Ohio Ramps up Medicaid Program Integrity Initiative with Provider Suspensions and Fraud Room
The Ohio Department of Medicaid (ODM) announced on June 4, 2026, that it is suspending 49 high-risk home health Medicaid providers that have exhibited red flags for fraud. The suspensions follow an executive order from Governor Mike DeWine that allows ODM to suspend payments based on credible allegations. As part of the state’s wider efforts to combat fraud, waste, and abuse, Ohio also announced that it is opening a state-specific “Medicaid Fraud Room” to prevent and locate fraud.
Private Market News
Fueled By Wakely Consulting Group
Inspector General Finds Millions in Potential Overpayments to Medicare Advantage Plans
The Inspector General for the Department of Health and Human Services released findings from its of payment to Medicare Advantage (MA) plans. According to the OIG, the Centers for Medicare & Medicaid Services may have made about $462 million in overpayments to MA plans in 2021 due to unsupported acute stroke diagnoses that were not backed by medical records. Read more from the Wakely Wire.
Our Insights
Fueled By Experts Across Our HMA Companies
Health Management Associates
A Summer Webinar Series (July 15): Understanding Work and Community Engagement Requirements
This webinar series will deliver timely analysis and actionable insights on the evolving policy and operational environment affecting Medicaid funding, enrollment, and access to services. Each session will feature up-to-the-moment information and perspectives from our subject matter experts, with content tailored to reflect the latest federal guidance, waiver activity, litigation, state implementation decisions, and market developments.
A Summer Webinar Series (August 12): How New Program Integrity Expectations Affect Medicaid Payments
This webinar series will deliver timely analysis and actionable insights on the evolving policy and operational environment affecting Medicaid funding, enrollment, and access to services. Each session will feature up-to-the-moment information and perspectives from our subject matter experts, with content tailored to reflect the latest federal guidance, waiver activity, litigation, state implementation decisions, and market developments.
Final 2027 Notice of Benefit and Payment Parameters: What States and Issuers Need to Know
What are the changes in the payment notice for 2027? On May 15, 2026, the Department of Health and Human Services (HHS) and the Centers for Medicare & Medicaid Services (CMS) released the final Notice of Benefit and Payment Parameters (NBPP) for 2027, setting key rules for the individual and small group health insurance markets. This report explains the most important 2027 Payment Notice changes for health care payers, issuers, state regulators, and state-based exchanges—including what CMS finalized, what changed from the proposed rule, what takes effect in 2026, 2027, and 2028, and what the rule signals for future marketplace policy.
Leavitt Partners
Opportunities to Address Health-Related Social Needs in Medicaid Remain Possible and Prevalent
Medicaid programs are the primary provider of healthcare benefits to tens of millions of Americans with limited incomes and resources, many of whom may experience food and nutrition insecurity and other health-related social needs (HRSNs), which have a significant impact on healthcare spending and health outcomes.
Vital Viewpoints Podcast
The Coverage Gap Grows: ACA Changes Reverberate Across Healthcare
Listen HereRFP Calendar
RFP Calendar
| Date | State/Program | Event | Beneficiaries |
|---|---|---|---|
| Date: June 24, 2026 | State/Program: Wisconsin LTC GSR 3 | Event: Awards | Beneficiaries: 56,000 (all GSR) |
| Date: Summer 2026 | State/Program: Illinois Foster Care | Event: RFP Release | Beneficiaries: 33,000 |
| Date: July 1, 2026 | State/Program: Hawaii Community Care Services | Event: Implementation | Beneficiaries: 5,500 |
| Date: July 28, 2026 | State/Program: Nevada Children's Specialty | Event: Awards | Beneficiaries: NA |
| Date: August 2026 | State/Program: Indiana | Event: RFP Release | Beneficiaries: 1,400,000 |
| Date: January 1, 2027 | State/Program: Illinois | Event: Implementation | Beneficiaries: 2,400,000 |
| Date: January 1, 2027 | State/Program: Nevada CO D-SNP | Event: Implementation | Beneficiaries: 88,000 |
| Date: January 1, 2027 | State/Program: Wisconsin LTC GSR 3 | Event: Implementation | Beneficiaries: 56,000 (all GSR) |
| Date: January 1, 2027 | State/Program: Illinois Tailored Care Management Program | Event: Implementation | Beneficiaries: 22,400 |
| Date: July 1, 2027 | State/Program: Nevada Children's Specialty | Event: Implementation | Beneficiaries: NA |
| Date: January 1, 2028 | State/Program: Wisconsin LTC GSR 4,6 | Event: Implementation | Beneficiaries: 56,000 (all GSR) |
| Date: Fall 2027 | State/Program: Oregon | Event: RFP Release | Beneficiaries: 1,200,000 |
| Date: 2028 | State/Program: North Carolina | Event: RFP Release | Beneficiaries: 2,200,000 |
| Date: 2029 | State/Program: California | Event: RFP Release | Beneficiaries: NA |